GlassScriptPhysician profile
Solomon Laktineh
NPI 1891820627
$2,520.54
in general payments reported to CMS, 2019-2025
17 companies · $711 in 2025
The $711 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $216 · 2021: $239 · 2022: $353 · 2023: $347 · 2024: $388 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,446.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $708.33 | 2019-2025 | Bexsero |
| Merck Sharp & Dohme LLC | $380.50 | 2019-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Pfizer INC. | $313.09 | 2019-2025 | |
| Sanofi Pasteur INC. | $295.70 | 2019-2025 | |
| Cranial Technologies, INC | $281.34 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $171.39 | 2024-2025 | |
| Phadia US INC. | $66.07 | 2022-2024 | Immunocap |
| Verrica Pharmaceuticals INC. | $48.77 | 2025 | Ycanth |
| Seqirus USA INC | $48.41 | 2022-2025 | Flucelvax |
| Cipher Pharmaceuticals US LLC | $47.05 | 2025 | Spinosad, Natroba |
| Organon LLC | $35.97 | 2021 | |
| Abbott Laboratories | $30.33 | 2025 | Id Now Instrument |
| Hologic Sales and Service, LLC | $24.37 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $18.46 | 2025 | Neffy |
| Evofem Biosciences, INC. | $17.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Solomon Laktineh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.